Pharma Intelligence (Biomedtracker) puts the probability of success of a non-cancer, rare disease drug, transitioning from NDA to approval, to be 93.6% (Ref. p.13).
The analyst is entitled to her opinion but I’ll go with Biomedtracker’s odds.
Share Price, page-1015
-
- There are more pages in this discussion • 10,461 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.34 |
Change
-0.410(2.60%) |
Mkt cap ! $1.960B | |||
| Open | High | Low | Value | Volume |
| $15.88 | $15.93 | $15.34 | $6.463M | 415.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 6044 | $15.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.57 | 1411 | 2 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |